Arcturus Therapeutics (NASDAQ:ARCT) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Arcturus Therapeutics (ARCT) operate in?

Arcturus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Arcturus Therapeutics Stock (NASDAQ: ARCT) stock price, news, charts, stock research, profile.

Open	$14.70
Close	$15.48
Volume / Avg.	812.43K / 393.43K
Day Range	$14.61 - $15.80
52 Wk Range	14.30 - 45.00
Market Cap	$419.31M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	25.29%
Days to Cover	9.29

Recent News

Arcturus Therapeutics/CSL Partnered COVID-19 Vaccine Surpasses Pfizer's Comirnaty Shot, Even At Lower Doses

CSL and Arcturus Therapeutics report that their sa-mRNA COVID-19 vaccine, ARCT-154, delivered superior immunogenicity compared to Pfizer's Comirnaty in a Phase 3 study, persisting for one year and at a lower dose.

Vandana Singh

Does Arcturus Therapeutics Have the Potential to Rally 216.35% as Wall Street Analysts Expect?

Arcturus Therapeutics (NASDAQ: ARCT) closed the last trading session at $21.10, gaining 2.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide.

Zacks

AN2 Therapeutics Plunges 66% in a Month: Here's Why

AN2 Therapeutics (NASDAQ: ANTX), a clinical-stage company, leverages its boron chemistry platform to develop novel small molecule therapeutics to potentially treat various infectious diseases and cancer indications.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Sep

Oct

Nov

Dec

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.3

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$14.70
Close	$15.48
Volume / Avg.	812.43K / 393.43K
Day Range	$14.61 - $15.80
52 Wk Range	14.30 - 45.00
Market Cap	$419.31M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	25.29%
Days to Cover	9.29

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Arcturus Therapeutics (ARCT) stock?

You can purchase shares of Arcturus Therapeutics (NASDAQ:ARCT) through any online brokerage.

View our list of the best stock brokerages

Who are Arcturus Therapeutics (ARCT) competitors?

Other companies in Arcturus Therapeutics’s space includes: Humacyte (NASDAQ:HUMA), KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Celcuity (NASDAQ:CELC) and Korro Bio (NASDAQ:KRRO).

What is the forecast, or price target, for Arcturus Therapeutics (ARCT) stock?

Arcturus Therapeutics has a consensus price target of $50.18.

What is the current price for Arcturus Therapeutics (ARCT)?

The stock price for Arcturus Therapeutics (NASDAQ: ARCT) is $15.48 last updated December 20, 2024 at 4:11 PM EST.

Does Arcturus Therapeutics (ARCT) pay a dividend?

There are no upcoming dividends for Arcturus Therapeutics.

When is Arcturus Therapeutics (NASDAQ:ARCT) reporting earnings?

Arcturus Therapeutics’s Q4 earnings are confirmed for Thursday, March 6, 2025.

Is Arcturus Therapeutics (ARCT) going to split?

There is no upcoming split for Arcturus Therapeutics.

What sector and industry does Arcturus Therapeutics (ARCT) operate in?

Arcturus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Arcturus Therapeutics

Arcturus Therapeutics (ARCT) Forecast

Arcturus Therapeutics (NASDAQ:ARCT) Stock Quotes, Forecast and News Summary

Recent News

Financials

Analyst Trends and Forecast

Analyst Rating and Forecast

Compare

FAQ

How do I buy Arcturus Therapeutics (ARCT) stock?

Who are Arcturus Therapeutics (ARCT) competitors?

What is the forecast, or price target, for Arcturus Therapeutics (ARCT) stock?

What is the current price for Arcturus Therapeutics (ARCT)?

Does Arcturus Therapeutics (ARCT) pay a dividend?

When is Arcturus Therapeutics (NASDAQ:ARCT) reporting earnings?

Is Arcturus Therapeutics (ARCT) going to split?

What sector and industry does Arcturus Therapeutics (ARCT) operate in?

People Also Watch

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga